Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

NCT01147939

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Scripps Cancer Center Clinical Research La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UCLA School of Medicine, Division of Hematology/Oncology Los Angeles, California, United States
  • Rocky Mountain Blood and Bone Marrow Transplant Program Denver, Colorado, United States
View all 73 locations
View Trial Details
Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

NCT01035502

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Duke University Medical Center Durham, North Carolina, United States
  • CHU Lyon, Hospital Edouard Herriot Lyon, France
  • Institut Paoli-Calmettes Marseille, France
  • CHU Toulouse, Hospital Purpan Toulouse, France
View Trial Details
Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

NCT01258816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • ICO - Hospital Duran i Reynals Barcelona, Catalonia, Spain
  • Hospital General de la Vall d' Hebron Barcelona, Spain
  • Hospital San Pedro Alcantara Cáceres, Spain
  • Brighton & Sussex University Hospitals NHS Trust Brighton, United Kingdom
View Trial Details
Completed

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00454480

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Royal United Hospital Bath, England, United Kingdom
  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
View all 96 locations
View Trial Details
Completed

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

NCT00684918

Conditions
AML, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • The University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions